Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Schiff

Showing results (351-360 of 424) with videos related to

Pageof 43
Sort By:
The New England Journal of Medicine|April 16, 1987
A serologic follow-up of the 1942 epidemic of post-vaccination hepatitis in the United States ArmyL B Seeff, G W Beebe, J H Hoofnagle, et al.
Hepatology (Baltimore, Md.)|July 27, 2007
Oral IDN-6556, an antiapoptotic caspase inhibitor, may lower aminotransferase activity in patients with chronic hepatitis CPaul J Pockros, Eugene R Schiff, Mitchell L Shiffman, et al.
Gastroenterology|July 1, 1993
Cell-mediated hepatic injury in alcoholic liver disease. Veterans Affairs Cooperative Study Group 275A Chedid, C L Mendenhall, T E Moritz, et al.
Alcoholism, Clinical and Experimental Research|October 1, 1995
Hepatitis C virus in alcoholic patients with and without clinically apparent liver diseaseM E Coelho-Little, L J Jeffers, D E Bernstein, et al.
Hepatology (Baltimore, Md.)|August 2, 2001
A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis CK L Lindsay, C Trepo, T Heintges, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 22, 2004
Outcomes in liver transplant recipients with hepatitis B virus: resistance and recurrence patterns from a large transplant center over the last decadeGuy W Neff, Christopher B O'brien, Jose Nery, et al.
Lancet (London, England)|January 4, 1997
Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantationM M Bartholomew, R W Jansen, L J Jeffers, et al.
Hepatology (Baltimore, Md.)|April 1, 1993
A study of oral nutritional support with oxandrolone in malnourished patients with alcoholic hepatitis: results of a Department of Veterans Affairs cooperative studyC L Mendenhall, T E Moritz, G A Roselle, et al.
The American Journal of Gastroenterology|June 18, 2003
Comparison of three commercially available assays for HCV RNA using the international unit standard: implications for management of patients with chronic hepatitis C virus infection in clinical practiceMitchell L Shiffman, Andrea Ferreira-Gonzalez, K Rajender Reddy, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 9, 2020
Multicenter, Double-Blind, Randomized Trial of Emricasan in Hepatitis C-Treated Liver Transplant Recipients With Residual Fibrosis or CirrhosisEthan M Weinberg, Michael P Curry, Catherine T Frenette, et al.
Pageof 43

Showing results (351-360 of 424) with videos related to

Sort By:
Pageof 43
The New England Journal of Medicine|April 16, 1987
A serologic follow-up of the 1942 epidemic of post-vaccination hepatitis in the United States ArmyL B Seeff, G W Beebe, J H Hoofnagle, et al.
Hepatology (Baltimore, Md.)|July 27, 2007
Oral IDN-6556, an antiapoptotic caspase inhibitor, may lower aminotransferase activity in patients with chronic hepatitis CPaul J Pockros, Eugene R Schiff, Mitchell L Shiffman, et al.
Gastroenterology|July 1, 1993
Cell-mediated hepatic injury in alcoholic liver disease. Veterans Affairs Cooperative Study Group 275A Chedid, C L Mendenhall, T E Moritz, et al.
Alcoholism, Clinical and Experimental Research|October 1, 1995
Hepatitis C virus in alcoholic patients with and without clinically apparent liver diseaseM E Coelho-Little, L J Jeffers, D E Bernstein, et al.
Hepatology (Baltimore, Md.)|August 2, 2001
A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis CK L Lindsay, C Trepo, T Heintges, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 22, 2004
Outcomes in liver transplant recipients with hepatitis B virus: resistance and recurrence patterns from a large transplant center over the last decadeGuy W Neff, Christopher B O'brien, Jose Nery, et al.
Lancet (London, England)|January 4, 1997
Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantationM M Bartholomew, R W Jansen, L J Jeffers, et al.
Hepatology (Baltimore, Md.)|April 1, 1993
A study of oral nutritional support with oxandrolone in malnourished patients with alcoholic hepatitis: results of a Department of Veterans Affairs cooperative studyC L Mendenhall, T E Moritz, G A Roselle, et al.
The American Journal of Gastroenterology|June 18, 2003
Comparison of three commercially available assays for HCV RNA using the international unit standard: implications for management of patients with chronic hepatitis C virus infection in clinical practiceMitchell L Shiffman, Andrea Ferreira-Gonzalez, K Rajender Reddy, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 9, 2020
Multicenter, Double-Blind, Randomized Trial of Emricasan in Hepatitis C-Treated Liver Transplant Recipients With Residual Fibrosis or CirrhosisEthan M Weinberg, Michael P Curry, Catherine T Frenette, et al.
Pageof 43